After getting an unsolicited bid in late June, Jamieson Wellness (JWEL) is getting taken out for $2.5B by Japanese conglomerate Kirin - who gets a strong foothold in North America…

… at a reasonable price, with the $45.75 per share offer representing ~14x NTM EBITDA - a ~30% premium to recent trading and in line with JWEL’s average valuation.

The willingness to pay up speaks to the durability of the Jamieson’s end markets, with an aging population providing support for decades to come…

… and a longevity focused younger demographic representing meaningful growth upside. Great company, tough to see this one go.

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.

You might be interested in…